Pharmacological management of male breast cancer-Reference-Cited by-同舟云学术

Pharmacological management of male breast cancer

Published:2020-06-04 Issue:12 Volume:21 Page:1493-1504
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Duso Bruno A.¹²³,Trapani Dario¹^ORCID,Marra Antonio¹²,D’Amico Paolo¹²,Guerini Rocco Elena²⁴,Fusco Nicola²⁴,Mazzarella Luca¹³,Criscitiello Carmen¹,Esposito Angela¹,Curigliano Giuseppe¹²

Affiliation:

1. Division of Early Drug Development, European Institute of Oncology (IEO), IRCCS , Milan, Italy

2. Department of Oncology and Hematology, University of Milan , Milan, Italy

3. Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS , Milan, Italy

4. Division of Pathology, European Institute of Oncology (IEO), IRCCS , Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1763305

Reference118 articles.

1. Male Breast Cancer: Epidemiology and Risk Factors

2. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

3. Breast cancer statistics, 2019

4. European cancer mortality predictions for the year 2019 with focus on breast cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond;Cancers;2024-01-30

2. Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer;Breast Cancer Research and Treatment;2022-12-09

3. An Update on the General Features of Breast Cancer in Male Patients—A Literature Review;Diagnostics;2022-06-26

4. Mexican consensus on breast cancer diagnosis and treatment;Gaceta Mexicana de Oncolog�a;2021-11-24